Pioglitazone, Body Composition,Insulin Sensitivity and Protein Metabolism in ESRD

NCT01253928 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

16

Enrollment

OTHER

Sponsor class

Conditions

ESRD

Interventions

DRUG: Pioglitazone

Sponsor

Centre Hospitalier Universitaire Vaudois